A

Adaptive Biotechnologies Corp
D

ADPT

8.92500
USD
0.10
(1.08%)
مغلق
حجم التداول
48,436
الربح لكل سهم
-1
العائد الربحي
-
P/E
-9
حجم السوق
1,355,856,744
أصول ذات صلة
ABBV
ABBV
0.810
(0.44%)
183.260 USD
AMGN
AMGN
-0.04
(-0.01%)
271.89 USD
BIIB
BIIB
-0.465
(-0.37%)
125.825 USD
GILD
GILD
0.670
(0.63%)
107.390 USD
MRK
MRK
-0.220
(-0.28%)
77.600 USD
PFE
PFE
0.110
(0.47%)
23.330 USD
REGN
REGN
-8.04
(-1.35%)
588.61 USD
SNY
SNY
-0.515
(-0.98%)
51.995 USD
المزيد
الأخبار المقالات

العنوان: Adaptive Biotechnologies Corp

القطاع: Healthcare
الصناعة: Biotechnology
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product,clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is alsoavailable as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).